|
PEN's Revenue Growth by Quarter and Year
Penumbra Inc's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
PEN Revenue (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
4th Quarter |
December |
-
|
315.52
|
284.68
|
221.22
|
3rd Quarter |
September |
-
|
301.04
|
270.95
|
213.68
|
2nd Quarter |
June |
-
|
299.40
|
261.50
|
208.34
|
1st Quarter |
March |
324.14
|
278.66
|
241.40
|
203.90
|
FY |
|
324.14
|
1,194.62
|
1,058.53
|
847.14
|
PEN Revenue first quarter 2025 Y/Y Growth Comment |
Penumbra Inc reported Revenue increase of 16.32% year on year in the first quarter 2025, to $ 324.14 millions, this is lower than Penumbra Inc's recent average Revenue improvement of 28.04%.
Looking into first quarter 2025 results within Medical Equipment & Supplies industry 74 other companies have achieved higher Revenue growth. While Penumbra Inc' s Revenue growth of 16.32% ranks overall at the positon no. 1384 in the first quarter 2025.
|
PEN Revenue ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
December |
- |
10.83 % |
28.69 % |
8.44 % |
3rd Quarter |
September |
- |
11.11 % |
26.8 % |
12.39 % |
2nd Quarter |
June |
- |
14.49 % |
25.52 % |
13.07 % |
1st Quarter |
March |
16.32 % |
15.43 % |
18.39 % |
20.51 % |
FY |
|
- |
12.86 % |
24.95 % |
13.32 % |
PEN Revenue (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
December |
- |
4.81 % |
5.07 % |
3.53 % |
3rd Quarter |
September |
- |
0.55 % |
3.61 % |
2.56 % |
2nd Quarter |
June |
- |
7.44 % |
8.33 % |
2.18 % |
1st Quarter |
March |
2.73 % |
-2.11 % |
9.12 % |
-0.05 % |
FY (Year on Year) |
|
- |
12.86 % |
24.95 % |
13.32 % |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
139.05 % |
28.04 % |
2.38 % |
(Jun 30 2017) |
|
|
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
139.05 % |
28.04 % |
2.38 % |
(Jun 30 2017) |
|
|
|
Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Penumbra Inc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
43.73 % |
5.27 % |
-23.46 % |
(Sep 30 2020) |
|
|
PEN's I. Quarter Q/Q Revenue Comment |
Penumbra Inc achieved in the I. Quarter 2025 below company average Revenue growth of 2.73% quarter on quarter, to $ 324.14 millions.
I. Quarter 2025 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -2.11% in the I. Quarter a year ago.
Within Medical Equipment & Supplies industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Penumbra Inc's Revenue growth quarter on quarter, overall rank is 1164. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
43.73 % |
5.27 % |
-23.46 % |
(Sep 30 2020) |
|
|
PEN's I. Quarter Q/Q Revenue Comment |
Penumbra Inc achieved in the I. Quarter 2025 below company average Revenue growth of 2.73% quarter on quarter, to $ 324.14 millions.
I. Quarter 2025 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -2.11% in the I. Quarter a year ago.
Within Medical Equipment & Supplies industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Penumbra Inc's Revenue growth quarter on quarter, overall rank is 1164. |
|
Penumbra Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Mar 31 2025) |
12 Months Ending (Dec 31 2024) |
12 Months Ending (Sep 30 2024) |
12 Months Ending (Jun 30 2024) |
12 Months Ending (Mar 31 2024) |
Cumulative Revenue 12 Months Ending |
$ 1,240.10 |
$ 1,194.62 |
$ 1,163.78 |
$ 1,133.68 |
$ 1,095.78 |
Y / Y Revenue Growth (TTM) |
13.17 % |
12.86 % |
16.96 % |
20.89 % |
23.87 % |
Year on Year Revenue Growth Overall
Ranking |
# 367 |
# 103 |
# 112 |
# 106 |
# 519 |
Seqeuential Revenue Change (TTM) |
3.81 % |
2.65 % |
2.65 % |
3.46 % |
3.52 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 1384 |
# 450 |
# 376 |
# 274 |
# 955 |
Cumulative Revenue growth Comment |
Although Penumbra Inc's Annual Revenue growth year on year were below company's average 28.04% , Revenue announced in the Mar 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 13.17% year on year, from 12.86% in Dec 31 2024.
In the Healthcare sector 105 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 103 to 367. |
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
139.05 % |
28.04 % |
2.38 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 75 |
Sector |
# 248 |
S&P 500 |
# 1384 |
|
Cumulative Revenue growth
Comment |
Although Penumbra Inc's Annual Revenue growth year on year were below company's average 28.04% , Revenue announced in the Mar 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 13.17% year on year, from 12.86% in Dec 31 2024.
In the Healthcare sector 105 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 103 to 367. |
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
139.05 % |
28.04 % |
2.38 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 75 |
Sector |
# 248 |
S&P 500 |
# 1384 |
|